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Abstract
Diverticulosis is a common disease among Western and developed nations. 
Approximately 20% of patients with diverticulosis will become symptomatic. Acute 
diverticulitis is a common manifestation of diverticular disease. Different classifica-
tions exist to try to categorize it but, it is generally considered as complicated or 
uncomplicated. Eighty-five percent of patients with an acute onset of diverticulitis 
will have an uncomplicated presentation. The best way to assess the degree and 
severity of the disease is a CT scan along with some biochemical parameters like 
CRP. Recent guidelines from associations all over the world accept non-antibiotic 
therapy as a valid strategy of treatment for the non-complicated diverticulitis. 
Antibiotics are still compulsory in immune-compromised patients, the elderly, 
those with comorbidities, and those with signs of sepsis. Recommendations should 
be made on a case-by-case basis.
Keywords: uncomplicated diverticulitis, outpatient treatment, antibiotics, 
conservative management
1. Introduction
Diverticulosis is a common disease among the Western and developed nations; 
its prevalence increases with age, being 10% in adults over 40 years and around 
70% in patients over 80 years. Approximately 20% of patients with diverticulosis 
will become symptomatic [1].
Worldwide, the incidence of diverticular disease is rising. Lifestyle and Western 
diet seem to be the factors influencing this epidemiological change, increasing most 
dramatically among age groups between 18 and 64 years old. Amid young patients, 
diverticular disease is more common in men, while in the elderly population, the 
prevalence is similar between both sexes [2]. Diverticular disease can occur in any 
part of the colon, but the left side is more frequently affected in Western countries, 
while up to 70% of cases in Asia appear on the right side [3].
Different classifications exist to categorize acute diverticulitis, but it is gener-
ally classified as uncomplicated or complicated. The computed tomography of the 
“Antibiotics prescription was considered the standard procedure for an episode of 
acute noncomplicated diverticulitis; nowadays, in well-selected patients, antibiotics 
may be avoided.”
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abdomen and pelvis is the best way to assess its severity. Further investigations 
to characterize it include white blood cell count and C-reactive protein levels [4]. 
About 85% of patients that attend to the emergency department for an acute onset of 
diverticular disease will have an uncomplicated form of it, and they may be treated 
conservatively [5]. The rest of the cases will present with abscess, fistula, perforation, 
stricture, or peritonitis, where surgical treatment is advised in an urgent or elective 
setting. Surgical options are diverse, but the indications and recommendations to 
choose one strategy over the other are beyond the scope of this chapter.
Regarding nonoperative management, patients can be hospitalized or sent home 
with or without antibiotics. Treatment should be tailored according to the patient’s 
characteristics [6]. Patients with uncomplicated diverticulitis by CT may develop 
severe complications in 1.4% of the cases [7], while recurrence rates have been 
described to be from 5 to 20% [8]. Recurrence risk tends to be higher in patients 
with a previous episode of complicated diverticulitis (24% vs. 23.4%, p = 0.622) 
rather than in patients with uncomplicated diverticulitis, and most of these epi-
sodes occur within the first year [9] of the initial onset.
2. Discussion
2.1 Medical approach of uncomplicated diverticulitis
Diverticulitis treatment has been modified throughout time. The prescription of 
antibiotics used to be the therapeutic foundation of it, but it could be avoided now 
in well-selected patients [10]. The nonantibiotic treatment strategy was formulated 
more than a decade ago when diverticular physiopathology was reassessed. At 
first, it was known that diverticular occlusion, micro-perforation, and peritoneal 
infection were the origin of diverticulitis [11]. Later, with the finding of TNF-a 
overexpression, it was concluded that inflammation plays a crucial role in diverticu-
litis development [12]. Even more, patients with diverticular disease seem to have 
changed in the gastrointestinal flora, including the depletion of some fecal micro-
biota species that have anti-inflammatory properties [13]. Subjects with diverticula 
seem to have more macrophages in the intestinal wall than their healthier counter-
parts, promoting inflammation rather than infection [14] and therefore raising the 
question about the actual need for antibiotics for its treatment during an acute flare.
Under this hypothesis, anti-inflammatory medication has been suggested as a 
treatment for acute uncomplicated diverticulitis, spearing the use of antibiotics as 
long as complications are not present.
Two of the most important contributions regarding the avoidance of the use of 
antibiotics were made by the AVOD (Antibiotika Vid Okomplicerad Divertikulit—
Swedish for “antibiotics in uncomplicated diverticulitis”) and DIABOLO 
(DIverticulitis: AntiBiotics Or cLose Observation?) randomized control trials 
(RCT), published in 2011 and 2016, respectively.
The DIABOLO study [15] was a multicentric trial evaluating two different 
approaches for the management of uncomplicated acute diverticulitis, either 
observation or antibiotic treatment. The patients included were those with the first 
episode of left-sided uncomplicated diverticulitis, classified according to Hinchey’s 
or Ambrosetti’s scale. The diagnosis was confirmed with a CT scan in the first 24 h 
of presentation.
The antibiotic used was amoxicillin-clavulanic acid (unless allergic), and it was 
handed intravenously four times a day for the first 2 days and then switched to oral 
three times a day until a 10-day course was completed. For the initial doses, all the 
patients had to be admitted contrary to the observational group, which was treated 
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in the outpatient setting as long as the patient could tolerate a regular diet, there 
was no fever, and there was reasonable pain control. Only 34 patients were sent 
home under this premise.
The primary analyses included 528 patients. The median time to recovery during 
6 months follow-up was 14 days for patients who had conservative management vs. 
12 days among those with antibiotics. Readmission rates were comparable: 17.6% in 
the observation vs. 12.0% in the antibiotic group (p = 0.148).
The proportion of patients with recurrent diverticulitis was similar in the two 
groups (3.4 vs. 3.0%; p = 0.494). Rates of sigmoid resection were comparable (3.8 
vs. 2.3%; p = 0.323) for both emergency resection (0.8 vs. 1.1%; p = 0.553) and elec-
tive resection (3.1 vs. 1.1%; p = 0.254). In both groups, the most common reason for 
sigmoid resection was colonic obstruction (3 of 10 in the observation group vs. 2 of 
6 in the antibiotic group), followed by perforation (2 of 10 vs. 2 of 6).
Another multicenter trial was the AVOD [7], where 10 surgical departments in 
Sweden and one in Iceland participated. Uncomplicated diverticulitis was defined 
as an episode of clinical signs compatible with diverticulitis, including fever and 
raised inflammatory markers complemented with computed tomography (CT). The 
randomization was done with sealed envelopes, and the patients were treated with 
just intravenous fluids or with antibiotic therapy, but in any case, hospital admis-
sion was required. A total of 623 patients were enrolled in the study—309 patients 
in the no-antibiotics arm and 314 in the antibiotics group. In the antibiotics group, 
the treatment was initiated with an intravenous combination of a cephalosporin 
(cefuroxime or cefotaxime) and metronidazole, or with carbapenem antibiotics or 
piperacillin-tazobactam, and then changed to an oral regimen for completion of 7 
days. The discharge was made after the improvement of clinical and biochemical 
parameters in both groups. Further investigations with colonoscopy, barium enema, 
or CT colonography were made if none of these were performed within 1 year 
before admission at 6 or 8 weeks. No significant differences were found between 
patients treated with or without antibiotics. Neither did between the frequencies 
in surgery, length of hospital stay, recurrence of diverticulitis, chronic pain, or 
changes in bowel habit after 12 months.
This study group recently published a long-term follow-up of this cohort. At 
a median time of 11 years, the authors found no significant differences between 
the two groups in terms of recurrences (both 31.3%), complications, surgery for 
diverticulitis, or reported quality of life (EQ-5DTM) [16].
It is extremely important to mention that both trials supporting the avoidance of 
antibiotics included only patients with early-stage disease (Hinchey I and Ia). These 
RCTs are also prone to perform a selection bias because no blinding was made, and 
actual rates among centers were variable. Antibiotic treatment was also not stan-
dardized [17].
van Dijk et al. [18] made an individual-patient data meta-analysis with 1109 
patients of the DIABOLO and AVOD trials: 545 in the observational group and 564 
in the antibiotics group. To make results comparable, he redefined some of the con-
cepts evaluated—ongoing diverticulitis, recurrent diverticulitis, and complicated 
diverticulitis. Ongoing diverticulitis was the persistence of symptoms during the 
following 3 months after initial discharge, and recurrent diverticulitis was defined 
as any episode occurring after discharge. The mean duration of follow-up was 12 
months. Baseline characteristics were similar among groups; however, primary 
diverticulitis was slightly and significantly more common in the antibiotics group 
454 cases vs. 408 in the nonantibiotic (p = 0.029). The length of stay for the initial 
hospital admission was shorter, although nonsignificant in the observational group. 
The rate of ongoing diverticulitis was 7.2% (39 of 545) in the observational group 
vs. 5.0% (28 of 564) in the antibiotics group (p = 0.062). The rates of recurrent 
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diverticulitis were comparable: 8.6% (47 of 545) vs. 9.6% (54 of 564), respectively 
(p = 0.610). The rate of complicated diverticulitis within 1 month was 1.8% (10 of 
545) in the observational group vs. 1.1% (6 of 564) in the antibiotics group  
(p = 0.204); at 1-year follow-up, it was 4% (22 of 545) vs. 2.1% (12 of 564), respec-
tively (p = 0.079). Rates of sigmoid resection were no differences between the 
groups at 1 month or 1 year.
Other studies with less statistical power (non RCT) have had the same findings 
as to the DIABOLO and AVOD. Some meta-analyses have been made trying to 
gather more evidence about this topic, and the main outcomes address the recur-
rence, need for surgery, complication rate, and treatment failure.
A meta-analysis from Desai et al. [19], with seven studies for a total of 2241 
patients, concluded that recurrent diverticulitis was actually slightly higher among 
patients who received antibiotics compared with those who did not 12.6% vs. 11.5% 
[pooled rate of recurrent diverticulitis OR = 1.27 (95%, CI = 0.90–1.79); p = 0.18]. 
Total complications were higher among patients who had antibiotics 27.8% vs. 
19.85% [pooled OR = 1.99 (95% CI, 0.66–6.01); p = 0.22), and so was treatment fail-
ure 3% vs. 4.5% (pooled OR = 0.68 (95% CI, 0.42–1.09); p = 0.11], and readmission 
rates 14.5% vs. 15.2% [pooled OR = 0.75 (95% CI, 0.44–1.30); p = 0.31], pointing 
out that all negative outcomes tend to be lower in the nonantibiotic group, although 
no statistical significance was found in any of them. But it is also worth mentioning 
that the rate of sigmoidectomy was higher in the patients treated without antibiot-
ics, 1.5% vs. 4.8% [pooled OR = 3.37 (95% CI, 0.65–17.34); p = 0.15]. In the end, 
the benefit of treating patients without antibiotics was proven in fewer costs, less 
hospital stays, and less antibiotic resistance.
Emile et al. [20] published a systematic review of nine studies with 2565 
patients. Failure was defined as the deterioration of symptoms requiring an antibi-
otic prescription or the readmission within 1 month of discharge due to persistency 
of them, with or without complications. Recurrence was defined as a new episode 
of diverticulitis within 1 month after discharge, and readmission was defined as a 
hospital admission within 1 year after discharge. They concluded that there were 
no differences in treatment failure, (OR = 1.5, p = 0.06), recurrence (OR = 0.81, p = 
0.2), complications rate (OR = 0.56, p = 0.25), hospital readmissions (OR = 0.97, p 
= 0.91), need for surgery (OR = 0.59, p = 0.28), or mortality (OR = 0.64, p = 0.47). 
In this meta-analysis, the only predictor for failure in the nonantibiotic group was 
associated comorbidities (p < 0.001). Other authors found that a CRP higher than 
170 mg/dL was also associated with treatment failure.
A Cochrane systematic review from 2012 [21], including three randomized 
control trials, found no difference in outcomes between patients with uncompli-
cated diverticulitis treated with or without antibiotics. The patients included in the 
analyzed studies were healthy with a Hinchey I or Ia stage of the disease.
Mege and Yeo [22] made a meta-analysis including 2321 patients from 11 dif-
ferent studies. The primary endpoint was treatment failure, recognizing this as the 
need for emergency surgery (0.7% vs. 1.4%; p = 0.1). The secondary outcome was a 
recurrence, this being readmission for a new episode of acute diverticulitis 1 month 
after the previous episode (11% vs. 12%; p = 0.3). Then again, no difference was 
found. Emergency surgery occurred less frequently in the observational group than 
in the treatment group (0.5% vs. 1%, p = 0.34), and even elective surgery happened 
at comparable rates. But if we consider only the randomized control trials included, 
elective surgery occurred in 0.9% of the patients treated with antibiotics vs. 2.5% in 
the antibiotic group (p = 0.04).
The reason why elective surgery may be more frequently performed in patients 
in the nonantibiotic group might be the misperception of being undertreated, 
so they sought a definitive treatment. Antibiotics may reduce low-grade colonic 
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inflammation avoiding complications such as obstruction, recurrence, or ongoing 
diverticulitis [11].
Another meta-analysis included nine studies; two RCT, five cohort studies, 
and two case-control studies, with a total of 1164 patients. In this, patients treated 
without antibiotics required an additional intervention or treatment in 5.3% of the 
cases vs. the 3.6% on the antibiotic group but without statistical significance (risk 
ratio = 1.48; p = 0.28) [17]. The study concluded that treatment without antibiot-
ics is associated with a shorter hospital stay and no difference in readmission rates 
(risk ratio = 1.17; p = 0.26), need for surgical or radiological intervention (risk ratio 
= 0.61; p = 0.34), recurrence (risk ratio = 0.83; p = 0.21), and complications (risk 
ratio = 0.70–1.18; p = 0.67–0.91).
Mocanu et al. [23] performed another meta-analysis considering two RCT, 
one single-center cohort, two retrospective cohorts, one prospective cohort, one 
retrospective case control, and one prospective cohort single arm with a total of 
2469 patients. The outcomes included were—recurrence (readmission greater than 
1 month following intervention), treatment failure (recurrence of symptoms within 
1 month of intervention), abscess, bleeding, fistula, perforation, stenosis, and need 
for elective or emergent surgery. The overall complication rate was 18.7%, and there 
was no difference among groups 17.7% in the nonantibiotic group vs. 20.2% in the 
antibiotic group (OR = 0.72; CI = 0.45–1.16; p = 0.18). Recurrence was the most 
common seeing with a rate between 2 and 28%. The rates of abscesses, perforation, 
stenosis, elective and emergency surgery were also no different. There was a statisti-
cal difference in the length of stay being 1 day less for the nonantibiotic group. They 
concluded that antibiotic use in patients with acute uncomplicated diverticulitis is 
not associated with a reduction in significant complications.
Daniels et al. [24] ran a pragmatic RCT with the analysis of the information from 
528 patients. His observational strategy proved no inferiority when compared to the 
antibiotic treatment for the first episode of uncomplicated diverticulitis. The dura-
tion of initial admission was longer, and the rate of antibiotic-related adverse events 
was higher in the antibiotic group, suggesting that antibiotics can be omitted. He 
also mentions that 7.3% of the patients treated without antibiotics had ongoing 
diverticulitis vs. 4.7% in the antibiotic group p = 0.183.
Quality of life between both treatments has not been adequately addressed; 
there is a lack of information regarding this critical outcome. Ongoing diverticulitis 
might not be a precise indicator of the quality of life, but it does make reference to 
the persistency of symptoms, which may affect the quality of life of patients [24].
The number of days, type of antibiotics, and inpatient or outpatient adminis-
tration are the other questions arousing in regard to uncomplicated diverticulitis 
treatment. Antibiotic therapy must be effective against aerobic (Escherichia coli, 
Proteus, Klebsiella, and Enterococcus) and anaerobic (Bacteroides, Clostridium, 
Bifidobacterium, and Peptostreptococcus) bacteria. In general, a broad-spectrum anti-
biotic should be elected or combination therapy with metronidazole and quinolones 
or third-generation cephalosporins or beta-lactam antibiotics with a beta-lactamase 
inhibitor [10]. Under the premise of reducing antibiotic resistance and costs, Schug-
Pass et al. [25] designed a randomized trial to elucidate whether short-term therapy 
(4 days) with ertapenem is as effective as standard therapy (7 days) in an inpatient 
scenario. Randomization was conducted on day 4, with antibiotic therapy being 
then either terminated or continued for a further three days. In uncomplicated 
sigmoid diverticulitis, symptomatic improvement happens in the first 96 h. This 
prospective randomized trial demonstrated that a shorter 4-day treatment period is 
just as effective as the standard treatment (98.0% vs. 98.2%).
A prospective, single-arm study overviewed [26] the safety and efficacy of 
symptomatic (nonantibiotic) treatment for CT-proven uncomplicated acute 
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diverticulitis during a 30-day follow-up period. A total of 153 patients (95%) 
completed the follow-up. A total of 14 (9%) patients had pericolic gas. Altogether, 
140 (87%) patients were treated as outpatients, and four (3%) of them were admit-
ted to the hospital at some point. The primary outcome of this study was to find 
the progression to complicated diverticulitis. None of the subjects developed it or 
needed surgery, but 2 days (median) after inclusion, antibiotics were given to 14 
(9%, six orally, eight intravenously) patients.
Jackson and Hammond [27] did a systematic review back in 2014 justified by 
the lack of evidence to support the traditional inpatient treatment with bowel rest, 
intravenous fluids, and intravenous antibiotics. This review included nine stud-
ies (415 patients) where all, except for one, used either CT scan or US to confirm 
uncomplicated diverticulitis. Once the diagnosis was made, some protocols would 
discharge patients immediately on oral antibiotics and a liquid diet for 10 days. 
Other protocols would keep patients in the hospital for 24 h before sending them 
home. Three of the studies allowed some patients to have outpatient care even 
with abscesses between 2 and 3 cm. About 403 patients out of a total of 415 (97%) 
participants were successfully treated in the outpatient setting, concluding that a 
more progressive, ambulatory-based approach is effective and safe.
Another systematic review including 21 studies (11 prospectives, nine retrospec-
tives, and only one randomized trial) with 1781 patients was recently published 
by Cirocchi et al. [28]. Outpatient management for acute left diverticulitis was the 
primary outcome evaluated. The meta-analysis concluded that outpatient manage-
ment is safe. The overall failure rate was 4.3% (95% CI = 2.6–6.3%). Ambulatory 
treatment was associated with an estimated daily cost savings of between €600 and 
€1900 per patient treated.
With the growing evidence that antibiotic therapy is not essential for the treat-
ment of acute uncomplicated diverticulitis, several guidelines support the observa-
tional management in afebrile clinically stable cases.
A survey conducted in 2011 [29] between gastroenterologists and surgeons 
found a general opinion about antibiotics not being for everyone any longer. The 
Danish and Dutch guidelines from 2011 to 2012, respectively, do not recommend 
the routine use of antibiotics [30].
The American Gastroenterological Association in 2015 advised that antibiotics 
should be used selectively rather than routinely in patients [31]. Stating also that 
treatment with broad-spectrum antibiotics may not solve the symptomatology in 
patients with acute uncomplicated diverticulitis. However, antibiotics may decrease 
the risk of recurrence and diverticular complications in comparison with no 
antibiotics. The effect of antibiotics on the development of sepsis and the need for 
surgery or colostomy remains uncertain.
Recent guidelines from associations all over the world now consider nonanti-
biotic therapy as a valid strategy for uncomplicated acute diverticulitis, among this 
associations the American Society of Colorectal Surgeons Clinical practice guide-
lines for the treatment of left-sided colonic diverticulitis (2020) [32], the Second 
International Symposium on Diverticular Disease [33], held in Rome in 2016, and the 
2020 WSES guidelines [34] address that CT scan findings must be compatible with 
uncomplicated acute diverticulitis and patients must not show signs of sepsis. The 
WSES established that immunocompetent patients with uncomplicated diverticulitis 
without signs of systemic inflammation should not receive antibiotic therapy. This 
was supported too by last year’s ESCP guidelines [35]; the commissioning guide for 
colonic diverticular disease made by the Royal College of Surgeons of England [36] 
in 2014, and the Japanese Gastroenterological Association [37] in 2019.
The EAES and SAGES [38] guidelines also make a remark about the immu-
nocompetence of the patients, establishing those healthy individuals with 
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uncomplicated acute diverticulitis will have similar outcomes with just symptom-
atic treatment. The antibiotic prescription should be reserved for immunocompro-
mised patients and cases with sepsis. The recommendations from other societies 
can be found in Table 1.
Society Recommendation Grade of evidence References
World Society of 
Emergency Surgery 
(WSES): update of 
the guidelines for the 
management of acute 
colonic diverticulitis in 
the emergency setting 
(2020)
In immunocompetent 
patients with uncomplicated 
diverticulitis without signs 
of systemic inflammation, 
we recommend not to 
prescribe antibiotic therapy
1A Cochrane Review, 





of Colon and Rectal 
Surgeons (ASCRS): 
clinical practice 
guidelines for the 
treatment of left-sided 
colonic diverticulitis 
(2020)
Selected patients with 
uncomplicated diverticulitis 







Isacson et al., 
Van Dijk ST, 
COCHRANE, 
Estrada Ferrer et 
al., Desai et al., Au 
S et al., Emile et 




(ESCP): Guidelines for 
the management of 
diverticular disease of 
the colon (2020)
Patients with acute 
uncomplicated 
diverticulitis do not require 
antibiotics routinely. 
Antibiotic treatment 
should be reserved for 
immunocompromised 
patients and patients with 
sepsis
Strong AVOD, Isacson et 
al., van Dijk ST et 
al., Desai M et al., 
Daniels L et al.
EAES and SAGES 2018 
consensus conference 






with uncomplicated acute 
diverticulitis, symptomatic 
treatment without antibiotics 
provides similar outcomes to 
treatment with antibiotics
Weak Galetin T et al., 




Guideline on the 
Management of Acute 
Diverticulitis
Antibiotics should be 
used selectively rather 
than routinely in acute 
uncomplicated diverticulitis
Low quality AVOD, DIABOLO, 
Stollman AGA, 
Sultan S AGA, 
Graham et 
al., Peery AF, 





Technical Review on the 
Management of Acute 
Diverticulitis (2015)
Treatment with broad-
spectrum antibiotics for at 
least seven days may not 
improve symptom resolution. 
Nevertheless, it may decrease 
the risk of recurrence and 
diverticular complications
Low quality COCHRANE, 
Morris AM et 
al., DIABOLO, 
Daniels LUC, de 
Korte N A et al., 
Hjern F et al.
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2.2 Right-sided colonic uncomplicated diverticulitis.
Right-sided diverticulosis is a rare condition in the Western population, but it is 
often seen in Asian countries. Its prevalence does not increase with age as it hap-
pens with the sigmoid diverticula. Right colon diverticula are usually solitary, true 
(all layers), and congenital; muscle hypertrophy is not observed [39]. Acute right 
Society Recommendation Grade of evidence References
Guidelines of Diagnostics 




Antibiotic treatment is 
recommended when signs 
of generalized infection 
and affected general 
condition or signs of 
bacteremia or septicemia 
are present. Antibiotic 
treatment is recommended 
in immunocompromised 
patients
Level A2 Ridgway PF et al., 
AVOD Schug-Pass 
C et al.
Danish national guidelines 
for the treatment of 
diverticular disease
The use of antibiotics in 
uncomplicated diverticulitis 
is justified by septicemia, 
affected general condition, 
pregnancy, or immuno-
suppression. Antibiotics are 
not routinely recommended
Ib Kaiser et al., Sarin 
S, Chautems et al., 
Schug-Pass C et 
al., Byrnes MC et 
al., AVOD , Hjern 
F et al
Italian Society of Colon 
and Rectal Surgery. 
Practice parameters for 
the treatment of colonic 
diverticular disease: 
Guidelines
The suggestion of avoiding 
antibiotics in acute 
uncomplicated diverticulitis 
may not improve short- or 
long-term outcomes. Use only 
on a case-by-case basis
Ib AVOD, Andersen 
JC, et al., 
Westwood DA et 
al., Hjern F et al., 
DIABOLO
Diverticular disease: 
guidelines of the 
German Society for 
Gastroenterology, 
Digestive and Metabolic 
Diseases and the German 
Society for General and 
Visceral Surgery
In acute uncomplicated 
left-sided diverticulitis 
with no risk indicators for a 
challenging course, antibiotic 
therapy can be omitted subject 
to close clinical monitoring
Open 
recommendations
AVOD, Hjern F et 
al., Schug-Pass C 
et al.
Royal College of Surgeons 




There is low-level evidence 
that patients suitable for 
management at home may be 





Guidelines for colonic 
diverticular bleeding 
and colonic diverticulitis 
(2019)
Antibiotic therapy has been 
reported to be unnecessary for 
colonic diverticulitis without 
abscess or perforation, but no 
studies have been conducted 
in Japan. Therefore, the 
efficacy of antibiotic therapy 
among Japanese patients is 
currently unclear. Antibiotic 
therapy is considered 
acceptable in current clinical 
practice
C Brochmann ND 
et al., AVOD, 
DIABOLO, Isacson 
D et al., Daniels L 
et al.
Table 1. 
Recommendations on the treatment of noncomplicated acute left diverticulitis.
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diverticulitis episodes generally occur in middle-aged men [40]. Differential diag-
nosis is complex, and it is frequently misinterpreted as acute appendicitis. There is 
not much literature regarding the treatment for right-sided diverticulitis.
The only study we were able to find about this subject was the one made by 
Destek and Gül [41] with 22 patients. Nine (40.9%) were female, and 13 (59%) were 
male. The age range was 26–84 years, with a mean age of 50.9 years. The duration 
of symptoms (nausea, diarrhea, and pain) prior to hospitalization was 1–5 days. In 
general, leukocytosis was detected in 77.2% of all patients, and high CRP levels were 
found in all of them (100%). About 59% of the patients had diverticulitis in the 
right colon, and 41% of them had diverticulitis in the cecum. Patients were classi-
fied as Hinchey stage I or II. Symptomatic conservative treatment was applied in 19 
patients (86.3%). Oral intake was discontinued for 2 or 3 days, intravenous hydra-
tion therapy with balanced solutions was given, intravenous dual antibiotic therapy 
was applied, and after 2–8 days, they were discharged with oral regimes. A percu-
taneous drainage catheter was placed under sonography in four patients (18.1%) in 
whom the localized abscess did not regress with conservative treatment.
Generally speaking, most recent guidelines support the use of the same prin-
ciples already discussed for the treatment of right-sided diverticulitis.
2.3 Uncomplicated diverticulitis and diet
For years, patients have been instructed to consume a clear-liquid or low-residue 
diet (low fiber), or even to deprive themselves of food for bowel rest during the 
diverticulitis flare [42, 43]. Several guidelines have supported this. A survey con-
ducted in the Netherlands in 2011 showed that 83.2% of participating gastroenter-
ologists and surgeons advised some form of bowel rest [42], but the Dutch guideline 
of 2012 stated that an unrestricted diet could also be advised [44].
In the prospective, observational study published by Isacson et al. [45] in 2015, 
patients with confirming CT scan for uncomplicated diverticulitis were enrolled 
to receive recommendations on oral intake of fluids for the first 48 h followed by a 
liquid diet and then moving on to a complete diet as tolerated. Readmission within 
1 month with or without complications was defined as a management failure. In 
total, 155 patients were included in the study, and only four patients had treatment 
failure. Five patients (3.3%) had a recurrence within the 3-month follow-up period.
A prospective, uncontrolled study of an unrestricted diet in 86 patients with 
uncomplicated diverticulitis concluded that this was well tolerated, although 8% 
had serious adverse events and 20% had ongoing symptoms [46].
A high-dietary fiber diet is hypothesized to prevent diverticulitis reoccurrence 
by reducing the contact time between stool and diverticula [47]. There has been an 
increased in the use of  probiotic supplementation under the assumption of them 
decreasing the risk of infection and inflammation of the diverticula [48].
The systematic review of Dahl et al. [49] addressed the lack of high-quality 
reports and research about the dietary management of adults with acute, uncom-
plicated diverticulitis. However, generalized observations tended to agree that 
either a free diet or a restricted one is equal in terms of recovery. A multicenter 
trial is underway to evaluate an unrestricted vs. a progressive diet in uncomplicated 
diverticulitis.
3. Conclusions
The nonantibiotic management in patients with uncomplicated diverticulitis 
still has some unsettled topics like management of the right-sided or recurrent 
Diverticular Disease of the Colon – Recent Knowledge of Physiopathology, Endoscopic...
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uncomplicated disease; further investigation in different populations and world 
regions is needed. More supervision on antibiotic prescription needs to be encour-
aged in patients who receive therapy for acute diverticulitis to make a cost-effect 
analysis for each case [50].
In conclusion, antibiotics may not improve outcomes in acute uncomplicated 
diverticulitis, but the high mortality associated with sepsis requires clinicians to 
maintain a low threshold in high-risk individuals such as immunocompromised 
patients, the elderly, and those with comorbidities [51]. Therefore, recommenda-
tions should be made on a case-by-case basis. If antibiotic therapy is necessary, oral 
administration is equally as effective as intravenous administration, and an expedi-
tious switch from intravenous to oral may allow the fastest patient discharge.
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